REGN Regeneron Pharmaceuticals · Healthcare
Every AI judgment on REGN since day one — direction, confidence, evidence, counter-argument, and how each call settled against real market prices. Append-only: nothing can be edited or deleted.
Latest judgment
bullish 58% confidence · data through 2026-11-04 · settles 2026-11-12.
REGN gapped +13% on 2026-10-30 (8-K/10-Q catalyst, likely earnings beat) on 5x volume, then extended to ~975 before a sharp intraday reversal on 11-04 (high 991.73, close 930.67). Post-gap momentum and elevated volume favor modest continuation, but the rejection candle and stretched move argue for tempered confidence over the next 5 sessions.
Invalidation: A daily close below the 2026-10-30 gap area (~869 open / prior close ~818) or below 900 would void the bullish continuation thesis.
Judgment history
Full interactive timeline with candlestick chart is loading below.